Close Menu

Plasticell

Proteomics firm Cellzome said this week it has won more than €2.3 million ($3.1 million) in grants funding its participation in three separate research projects.

Plasticell has developed "serum-free protocols that direct the differentiation of Stemnion's stem cells into hard-to-obtain lineages."

Plasticell has formed a spinout called Progenitor Labs, which will focus on regenerative drug discovery.

The British stem cell research tools firm plans to use the funds to expand its business development and marketing activities.

The collaboration involves using Sigma-Aldrich's CompoZr zinc finger nuclease technology and Plasticell's CombiCult high-throughput screening system.

23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.

China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.

In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.

NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.